Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Trellis Bioscience
company
About
Trellis Bioscience is a therapeutic antibody company developing treatments for infectious diseases and oncology indications.
- San Francisco,California,United States
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 1998
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Trellis Bioscience develops a technology platform for cellular informatics. The company's technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of potential therapeutic interventions. The company is based in San Francisco, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
$28.57M
Trellis Bioscience has raised a total of
$28.57M
in funding over 2 rounds. Their latest funding was raised on
Oct 1, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 1, 2019 | Grant | $3.20M | 1 |
CARB-X
|
— | Detail |
| Nov 9, 2011 | Debt Financing | $235K | — | — | — | Detail |
| Aug 7, 2009 | Series Unknown | $11.71M | — | — | — | Detail |
| Feb 14, 2007 | Series B | $10M | 4 |
Novartis Venture Fund
|
— | Detail |
| Jan 2, 2004 | Series A | $3.42M | — | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Trellis Bioscience has made 1 investments. Their most recent investment was on
May 24, 2006, when Promedior raised $14M.
Investors
Number of Lead Investors
Number of Investors
2
5
Trellis Bioscience is funded by 5 investors.
CARB-X
and Novartis Venture Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
CARB-X
|
Yes | Grant |
|
Novartis Venture Fund
|
Yes | Series B |
Easton Capital
|
— | Series B |
Morgenthaler Ventures
|
— | Series B |
Pac-Link
|
— | Series B |
Employee Profiles
Number of Employee Profiles
6
Trellis Bioscience has 6 current employee profiles, including
Board member Jack M. Anthony
Board member
Board member
Executive
Executive
Employee
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
